Legis Daily

Right to Test Act

USA116th CongressHR-7017| House 
| Updated: 5/26/2020
Patrick T. McHenry

Patrick T. McHenry

Republican Representative

North Carolina

Cosponsors (9)
Chip Roy (Republican)Gregory F. Murphy (Republican)Scott Perry (Republican)Denver Riggleman (Republican)W. Gregory Steube (Republican)James Comer (Republican)Mark Walker (Republican)Tom Emmer (Republican)Ralph Norman (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Right to Test Act This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. Unless requested by the governor of the state, the Food and Drug Administration (FDA) may not, during the emergency, engage in certain enforcement actions related to such a test or device. Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 19, 2020

Latest Companion Bill Action

S 116-3769
Introduced in Senate
May 26, 2020
Introduced in House
May 26, 2020
Referred to the House Committee on Energy and Commerce.
  • May 19, 2020

    Latest Companion Bill Action

    S 116-3769
    Introduced in Senate


  • May 26, 2020
    Introduced in House


  • May 26, 2020
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • S 116-3769: Right to Test Act
  • S 116-4537: RECOVERY Act
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations

Right to Test Act

USA116th CongressHR-7017| House 
| Updated: 5/26/2020
Right to Test Act This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. Unless requested by the governor of the state, the Food and Drug Administration (FDA) may not, during the emergency, engage in certain enforcement actions related to such a test or device. Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 19, 2020

Latest Companion Bill Action

S 116-3769
Introduced in Senate
May 26, 2020
Introduced in House
May 26, 2020
Referred to the House Committee on Energy and Commerce.
  • May 19, 2020

    Latest Companion Bill Action

    S 116-3769
    Introduced in Senate


  • May 26, 2020
    Introduced in House


  • May 26, 2020
    Referred to the House Committee on Energy and Commerce.
Patrick T. McHenry

Patrick T. McHenry

Republican Representative

North Carolina

Cosponsors (9)
Chip Roy (Republican)Gregory F. Murphy (Republican)Scott Perry (Republican)Denver Riggleman (Republican)W. Gregory Steube (Republican)James Comer (Republican)Mark Walker (Republican)Tom Emmer (Republican)Ralph Norman (Republican)

Energy and Commerce Committee

Health

Related Bills

  • S 116-3769: Right to Test Act
  • S 116-4537: RECOVERY Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations